NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
36.53
-0.47 (-1.27%)
Nov 4, 2025, 4:00 PM EST - Market closed
NAMS Stock Forecast
Stock Price Forecast
The 10 analysts that cover NAMS stock have a consensus rating of "Strong Buy" and an average price target of $43.7, which forecasts a 19.63% increase in the stock price over the next year. The lowest target is $27 and the highest is $52.
Price Target: $43.7 (+19.63%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 4 | 4 | 5 | 5 | 4 | 4 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +42.35% | Oct 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +36.87% | Oct 17, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $45 | Buy | Initiates | $45 | +23.19% | Aug 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $39 | Buy | Maintains | $38 → $39 | +6.76% | Aug 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $27 | Hold | Initiates | $27 | -26.09% | Jul 17, 2025 |
Financial Forecast
Revenue This Year
32.26M
from 45.56M
Decreased by -29.19%
Revenue Next Year
18.22M
from 32.26M
Decreased by -43.52%
EPS This Year
-1.39
from -2.56
EPS Next Year
-1.88
from -1.39
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.5M | 70.6M | |||
| Avg | 32.3M | 18.2M | |||
| Low | 21.7M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.9% | 118.7% | |||
| Avg | -29.2% | -43.5% | |||
| Low | -52.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.16 | -0.87 | |||
| Avg | -1.39 | -1.88 | |||
| Low | -1.66 | -2.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.